Executive Summary
Law No. 76 of 2026 establishes, for the first time in Egypt, a comprehensive legal framework governing Biosafety and Biosecurity Facilities classified as Biosafety Level 3 (BSL-3) and Level 4 (BSL-4) — facilities engaged in research on high-risk infectious agents and toxins. The Law creates a new regulatory authority, the National Center for Biosafety and Biosecurity, and imposes an integrated licensing, supervision, and inspection regime on regulated facilities and their personnel, with data-ownership rules, strict security-clearance and accreditation requirements, and a severe criminal enforcement regime, including fines of up to EGP 50 million.
Key Highlights
- New Regulatory Framework: Law No. 76 of 2026 establishes the first comprehensive legal framework in Egypt for BSL-3 and BSL-4 facilities, covering licensing, supervision, and operation.
- National Center for Biosafety and Biosecurity: A new public authority with legal personality, nominally under the Prime Minister but with a Board chaired by a Ministry of Defense nominee and seats for Defense, Interior, and General Intelligence — reflecting a national-security-driven institutional design.
- Licensing Regime: Facilities and key personnel (Facility Director, Quality Manager, Laboratory Biosafety Officer) require licenses/permits; facilities must also obtain international accreditation, though the Law leaves the accrediting bodies and standards to the Board’s discretion pending Implementing Regulations.
- Fees: Facility licensing fees of up to EGP 1 million, plus individual permit fees of up to EGP 20,000 per authorized staff member.Data Ownership with Limits: Research data and outputs are owned by the license holder, but disclosure, use, and transfer are subject to Board authorization and national-security overrides.
- Transitional Period: Existing facilities must regularize their status within one year of the Implementing Regulations (extendable by one year), giving an effective compliance window of roughly 18 months.
- Penalties: Rigorous imprisonment and fines up to EGP 50 million for unlicensed activity, unauthorized import/removal of biological agents or isolates, and unauthorized disclosure of classified information (aggravated to a minimum 5-year sentence where national security is implicated); a voluntary-disclosure exemption is available under Article 55.
Areas / Sectors Affected
- Biotechnology & Life SciencesResearch
- Pharmaceutical & Healthcare Industry
- Universities & Academic Research Institutions
- National Security & Defense
- Regulatory Licensing & Compliance
Publication Information
Publisher : Saqaan & Partners – Advocates & Legal Consultants
Publication : Legal updates
Jurisdiction : Egypt
Professional Notice
This Legal Update is a professional publication of Saqaan & Partners – Advocates & Legal Consultants and reflects the Firm’s legal analysis, professional assessment, and commentary on the legal developments addressed herein.
The content is provided for general informational and professional purposes and is not intended to address the specific circumstances of any particular person or entity or to substitute for professional legal advice in relation to a specific matter. The publication of this Legal Update does not, by itself, establish a lawyer-client relationship.
Copyright
© Saqaan & Partners – Advocates & Legal Consultants. All Rights Reserved.
The legal analysis and professional commentary contained in this Legal Update are protected under applicable intellectual property laws as the work of Saqaan & Partners – Advocates & Legal Consultants.
This Legal Update may be downloaded and shared in its published form for professional, informational, or non-commercial purposes, provided that its attribution to the publisher is maintained. The legal analysis and professional commentary may not be reproduced, modified, republished, translated, or incorporated into any other work.
Legislation, regulations, decisions, judgments, and other official governmental materials referred to herein remain subject to their respective official sources and legal status.
